These findings indicate that Ang II promotes mitochondrial fragmentation and concurrent apoptosis in podocytes via the Sirt6‐ROCK1‐Drp1 pathway, which may offer a new therapeutic strategy for downstream overactivation of the RAAS in CKD. The gene discussed is AGT; the disease is chronic kidney disease.